Neuro-Sys

Neuro-Sys was founded in 2013 in order to meet the demand for contract research services in the area of CNS (Central Nervous System) and PNS (Peripheral Nervous System). We owe our reputation to our team of experts, including best-in-class neuropharmacologists, physicians, and neurologists, with more than 20 years experience in pharmaceutical and biotech companies.

 

We’re able to provide leading advanced mode of action models by continually investing in in-house research to develop our own understanding of the pathological pathways - which our partners trust.

We invest in the latest equipment which we adapt for our own automated platforms.  This enables us to provide the most advanced and robust services for our clients, increased frequency and results that can be replicated reliably.

logoCIR_b&w.png
Présentation de conférence

Awards

iconGreen.png

 WORLD'S BEST CRO 

Corporate Live Wire (UK), 2021

iconBW.png

TOP 10 CRO FOR 2021

Pharma Tech Outlook (USA), 2021

iconBW.png

50 LEADING COMPANIES

OF THE YEAR FOR 2020

The Silicon Review

(USA), 2020

iconBW.png

DRUG DEVELOPMENT COMPANY OF THE YEAR

Corporate Live Wire (UK), 2020

 
 

Leadership team

The Neuro-Sys team is composed of about twenty experts specialized in CNS and PNS.

 

Since its creation, Neuro-Sys has become the leading specialist in the design of particularly innovative, robust and reproducible in vitro and in vivo models.
It is used to accompanying its clients and partners throughout the world in the most complex projects.

IMG_0076_2.webp

Noelle CALLIZOT

PharmD, PhD, HDR

CSO

In_edited_edited.png
AH.jpg

Alexandre HENRIQUES

PhD, HDR

Director of Pharmacology

In_edited_edited.png
20200219_172818_edited.webp

Laura ROUVIERE

PhD

In Vitro Group Leader

In_edited_edited.png
20211001_160620_square.jpg

Bilal EL WALY

PhD

In Vivo Group Leader

In_edited_edited.png
LS__2615.jpg

Yann JAUDOUIN

MBA

CEO

In_edited_edited.png
 

Scientific

Advisory

Board

Science and R&D are the key elements to ensure a better understanding of the pharmacological mechanisms of neurodegenerative diseases and the development of new models.

 

Neuro-Sys' SAB is composed of experts in their fields to support and optimize the company's R&D efforts during monthly meetings.

PP.jpg

Pr Philippe POINDRON

PharmD, PhD

Chairman

Members of the SAB:

Pr Jean-Philippe LOEFFLER

PhD

Pr Jean MARIANI

MD, PhD

Pr Jean-Claude STOCLET

PharmD, PhD

Pr Michel VIGNES

PhD

State-of-the-art

Facilities

Since its creation, Neuro-Sys has continued to invest in the latest generation of equipment and to train its staff to ensure the highest quality services.


The in vitro department has a unique robotic platform designed to specifications. It ensures better speed, robustness and high reproducibility.


The in vivo department has the best surgical and video tracking technologies that ensure high precision results.
The histology department has one of the most advanced miscroscopic platforms and an experienced team.

 
 

Partners

H2020_edited.jpg
46498_edited.jpg
CNRS_b&w.jpg
BPI_b&w.png
logo-TOTAL-dvptregional_b&w.jpg
Logo CAAP capital & innovation HD_b&w.jpg
Airbus_logo_black_edited.png
ANR-logo-2021_edited.jpg
Region sud_b&w.png
NOVA LOGO_edited.jpg